Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research

…, PR Ebeling, TA Einhorn, HK Genant… - Journal of bone and …, 2014 - academic.oup.com
Bisphosphonates (BPs) and denosumab reduce the risk of spine and nonspine fractures.
Atypical femur fractures (AFFs) located in the subtrochanteric region and diaphysis of the femur …

Treatment of painful osteoporotic vertebral fractures with percutaneous vertebroplasty or kyphoplasty

NB Watts, ST Harris, HK Genant - Osteoporosis International, 2001 - Springer
Vertebral fracture is the most common complication of osteoporosis. It results in significant
mortality and morbidity, including prolonged and intractable pain in a minority of patients. …

Clinical applications of body composition measurements using DXA

CV Albanese, E Diessel, HK Genant - Journal of Clinical Densitometry, 2003 - Elsevier
Dual-energy X-ray absorptiometry (DXA) scanning was primarily developed for the diagnosis
of osteoporosis and was initially applied to studies of the clinically important sites of the …

Vertebral fracture assessment using a semiquantitative technique

HK Genant, CY Wu, C Van Kuijk… - Journal of bone and …, 1993 - Wiley Online Library
Genant HK, Sdrensen OH 1990 Effects of intermittent cyclical etidronate therapy on bone
mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322:1265-…

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

…, DE Thompson, MC Nevitt, DC Bauer, HK Genant… - The Lancet, 1996 - thelancet.com
Background Previous studies have shown that alendronate can increase bone mineral
density (BMD) and prevent radiographically defined (morphometric) vertebral fractures. The …

[HTML][HTML] Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

…, EF Eriksen, S Ish-Shalom, HK Genant… - New England journal …, 2001 - Mass Medical Soc
Background Once-daily injections of parathyroid hormone or its amino-terminal fragments
increase bone formation and bone mass without causing hypercalcemia, but their effects on …

Bone density at various sites for prediction of hip fractures

…, W Browner, DM Black, MC Nevitt, HK Genant… - The Lancet, 1993 - Elsevier
Women with low bone density in the radius or calcaneus are at increased risk of hip fracture.
To see whether bone density of the hip measured by dual X-ray absorptiometry is a better …

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial

…, BH Mitlak, RK Knickerbocker, T Nickelsen, HK Genant… - Jama, 1999 - jamanetwork.com
ContextRaloxifene hydrochloride, a selective estrogen receptor modulator, prevents bone
loss in postmenopausal women, but whether it reduces fracture risk in these women is not …

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial

ST Harris, NB Watts, HK Genant, CD McKeever… - Jama, 1999 - jamanetwork.com
ContextRisedronate, a potent bisphosphonate, has been shown to be effective in the treatment
of Paget disease of bone and other metabolic bone diseases but, to our knowledge, it …

[HTML][HTML] The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

…, S Pors-Nielsen, R Rizzoli, HK Genant… - … England Journal of …, 2004 - Mass Medical Soc
Background Osteoporotic structural damage and bone fragility result from reduced bone
formation and increased bone resorption. In a phase 2 clinical trial, strontium ranelate, an orally …